N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial - eClinicalMedicine
N-acetylcysteine in substance use disorder: a lesson from preclinical and clinical research | SpringerLink
Current N-acetyl cysteine (NAC) in Obsessive Compulsive Disorders (OCD)... | Download Scientific Diagram
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review - ScienceDirect
Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children | PLOS ONE
Antenatal N-acetylcysteine to improve outcomes of premature infants with intra-amniotic infection and inflammation (Triple I): randomized clinical trial | Pediatric Research
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review - ScienceDirect
Summary of the potential effects of NAC supported by studies based on... | Download Table
N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspectiv | JIR
High-dose N-acetylcysteine for long-term, regular treatment of early-stage chronic obstructive pulmonary disease (GOLD I–II): study protocol for a multicenter, double-blinded, parallel-group, randomized controlled trial in China | Trials | Full Text
Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial - Journal of Cystic Fibrosis
Oral N‑acetylcysteine for prophylaxis of contrast‑induced nephropathy in patients following coronary angioplasty: A meta‑analysis
N-Acetylcysteine (NAC) cannot increase cellular Glutathione levels - Glutathione Reporter
Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial - The Journal of Thoracic and Cardiovascular Surgery
Clinical Trials on N-Acetylcysteine | SpringerLink
N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review. - Abstract - Europe PMC
N-acetylcysteine: A rapid review of the evidence for effectiveness in treating COVID-19 - The Centre for Evidence-Based Medicine
Clinical Trials on N-Acetylcysteine | SpringerLink
Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial - The Lancet Respiratory Medicine
The N-ICE trial: A randomised controlled trial of the safety and efficacy of N-acetyl cysteine (NAC) as a pharmacotherapy for methamphetamine ('ice') dependence | NDARC - National Drug and Alcohol Research Centre
NAC Attack Clinical Trial
Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial - The Lancet
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review - ScienceDirect
Flow chart for the clinical trial N-Acetylcysteine + risperidone versus... | Download Scientific Diagram
NAC Attack Clinical Trial
PLOS ONE: Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children
